title: The future of neuroprotection.
authors.affiliation: Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079-9502, USA. wslikker@nctr.fda.gov
authors.forename: W
authors.initials: W
authors.lastname: Slikkker
authors.forename: M
authors.initials: M
authors.lastname: Youdim
authors.forename: G C
authors.initials: GC
authors.lastname: Palmer
authors.forename: E
authors.initials: E
authors.lastname: Hall
authors.forename: C
authors.initials: C
authors.lastname: Williams
authors.forename: B
authors.initials: B
authors.lastname: Trembly
mesh_terms: D000818:Animals; D001930:Brain Injuries / Q000378:metabolism / Q000628:therapy; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy; D017382:Reactive Oxygen Species / Q000378:metabolism; D020521:Stroke / Q000188:drug therapy
chemical_list: D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species